U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
188371188371Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.CompletedNo Results AvailableAnxiety DisordersDrug: risperidone oral tabletshttps://ClinicalTrials.gov/show/NCT00086112
188372188372Study Evaluating the Addition of Amifostine (Ethyol®) to Idarubicin and Cytosine Arabinoside in Older Patients With Acute Myeloid LeukemiaCompletedNo Results AvailableLeukemia|Acute Myeloid LeukemiaDrug: Idarubincin and Amufostine (Ethyol)|Drug: Idarubincinhttps://ClinicalTrials.gov/show/NCT00086099
188373188373Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & AnemiaCompletedNo Results AvailableCongestive Heart Failure|AnemiaDrug: Darbepoetin Alfahttps://ClinicalTrials.gov/show/NCT00086086
188374188374Parkinson's Research: The Organized Genetics InitiativeCompletedNo Results AvailableParkinson Diseasehttps://ClinicalTrials.gov/show/NCT00086073
188375188375Pain Management Techniques for FibromyalgiaCompletedNo Results AvailableFibromyalgiaBehavioral: Exercise regimen|Behavioral: Relaxation training|Behavioral: Standard Carehttps://ClinicalTrials.gov/show/NCT00086060
188376188376Coping Skills Training for Adolescents With FibromyalgiaCompletedHas ResultsFibromyalgiaBehavioral: Coping Skills Training|Behavioral: Educationhttps://ClinicalTrials.gov/show/NCT00086047
188377188377Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's LymphomaCompletedNo Results AvailableLymphoma|Non-Hodgkin's LymphomaDrug: Motexafin gadoliniumhttps://ClinicalTrials.gov/show/NCT00086034
188378188378Acupuncture for the Treatment of Chronic Daily HeadachesCompletedNo Results AvailableHeadache DisordersProcedure: Acupuncturehttps://ClinicalTrials.gov/show/NCT00086021
188379188379Progression of Spinal Fusion in Ankylosing SpondylitisRecruitingNo Results AvailableSpondylitis, Ankylosinghttps://ClinicalTrials.gov/show/NCT00085995
188380188380Effect of Leptin Therapy in the Treatment of Severe Insulin ResistanceRecruitingNo Results AvailableInsulin ResistanceDrug: Metreleptinhttps://ClinicalTrials.gov/show/NCT00085982
188381188381Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes MellitusCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: Placebo 0.04 mL twice daily|Drug: Placebo 0.04 mL once daily|Drug: Placebo 0.08 mL once daily|Drug: B - Exenatide 10 mcg twice daily|Drug: C - Exenatide 10 mcg once daily|Drug: Exenatide 20 mcg once dailyhttps://ClinicalTrials.gov/show/NCT00085969
188382188382Effects of Arzoxifene on Bone Mass and the UterusCompletedNo Results AvailablePostmenopausal Bone LossDrug: Arzoxifene|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00085956
188383188383KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 WeeksCompletedNo Results AvailableHIV Infection|Infection, Human Immunodeficiency VirusDrug: LEXIVA (GW433908)|Drug: Ritonavir|Drug: KALETRA|Drug: EPIVIR|Drug: Ziagen|Drug: Abacavir/Lamivudine|Drug: Fosamprenavirhttps://ClinicalTrials.gov/show/NCT00085943
188384188384Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma PatientsActive, not recruitingNo Results AvailableNeuroblastomaBiological: 14g2a.zeta chimeric receptor transduced autologous EBV specific cytotoxic T-lymphocytes (EBV-CTL) w/o lymphodepletionhttps://ClinicalTrials.gov/show/NCT00085930
188385188385Peginterferon Alpha-2a and Ribavirin to Treat Hepatitis C in HIV-infected PatientsCompletedHas ResultsHepatitis C|HIV InfectionsDrug: Double dose pegylated interferon with weight based Ribavirin|Drug: standard dose pegylated interferon alfa -2a and ribavirinhttps://ClinicalTrials.gov/show/NCT00085917
188386188386Dose-Escalating Study Of SB-485232 Administered Intravenously Every 28 Days To Adults With Solid Tumors Or LymphomasCompletedNo Results AvailableSolid Tumor Cancer|LymphomaDrug: SB-485232https://ClinicalTrials.gov/show/NCT00085904
188387188387Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Quetiapine Fumaratehttps://ClinicalTrials.gov/show/NCT00085891
188388188388Dose-Escalation Study Of SB-485232 Administered As Daily Subcutaneous Injections In Adults With Solid TumorsCompletedNo Results AvailableSolid Tumor CancerDrug: SB-485232https://ClinicalTrials.gov/show/NCT00085878
188389188389Serotonin Transporters in AlcoholismCompletedNo Results AvailableAlcoholismhttps://ClinicalTrials.gov/show/NCT00085865
188390188390US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial FormulationCompletedNo Results AvailablePulmonary EmphysemaBiological: BLVRhttps://ClinicalTrials.gov/show/NCT00085852
188391188391Erlotinib vs. Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) and Eastern Cooperative Oncology Group (ECOG)Performance Status (PS) 2CompletedHas ResultsNon-Small Cell Lung CancerDrug: Tarceva (Trademark) (erlotinib HCl, OSI-774)|Drug: Combination carboplatin and paclitaxelhttps://ClinicalTrials.gov/show/NCT00085839
188392188392A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer PatientsCompletedNo Results AvailableNon-Small Cell Lung CancerDrug: Exisulindhttps://ClinicalTrials.gov/show/NCT00085826
188393188393Ispinesib In Patients With Advanced Or Metastatic Non-Small Cell Lung CancerCompletedNo Results AvailableNon-Small-Cell Lung CancerDrug: Ispinesibhttps://ClinicalTrials.gov/show/NCT00085813
188394188394Dietary Fiber and Cardiovascular Inflammatory MarkersCompletedNo Results AvailableCardiovascular Diseases|Heart Diseases|Diabetes Mellitus, Non-Insulin Dependent|Hypertension|Obesity|Inflammationhttps://ClinicalTrials.gov/show/NCT00085800
188395188395A Study of ARRY-142886 in Patients With Advanced CancerCompletedNo Results AvailableAdvanced CancerDrug: ARRY-142886, MEK inhibitor; oralhttps://ClinicalTrials.gov/show/NCT00085787
188396188396Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced AsthmaCompletedNo Results AvailableExercise-induced BronchospasmDrug: albuterol aerosol by HFA MDI|Drug: albuterol aerosol by HFA BOI|Drug: placebo aerosol by HFAhttps://ClinicalTrials.gov/show/NCT00085774
188397188397Study of NGX-4010 for Treatment of Painful HIV-Associated NeuropathyTerminatedNo Results AvailableHIV Infections|Peripheral Nervous System Diseases|PainDrug: Capsaicin Dermal Patchhttps://ClinicalTrials.gov/show/NCT00085761
188398188398Safety Study With Paliperidone ER Extended-Release (ER) Tablets in Geriatric Patients With SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: paliperidone ERhttps://ClinicalTrials.gov/show/NCT00085748
188399188399Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk MedulloblastomaActive, not recruitingNo Results AvailableBrain Tumor|Central Nervous System TumorDrug: cisplatin|Drug: cyclophosphamide|Drug: lomustine|Drug: vincristine sulfate|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00085735
188400188400Joint Injections for Osteoarthritic Knee PainActive, not recruitingNo Results AvailableOsteoarthritisProcedure: Dextrose Prolotherapy|Procedure: Saline Prolotherapy|Other: At-home physical therapy exercise grouphttps://ClinicalTrials.gov/show/NCT00085722

* Görseller ve İçerik tekif hakkına sahip olabilir